David M Jackman Selected Research

David M Jackman Research Topics

25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2016 - 07/2006
20	Neoplasms (Cancer) 12/2016 - 07/2006
9	Lung Neoplasms (Lung Cancer) 09/2016 - 03/2007
7	Neoplasm Metastasis (Metastasis) 04/2016 - 09/2006
5	Disease Progression 12/2016 - 03/2007
3	Brain Neoplasms (Brain Tumor) 08/2012 - 10/2005
3	Mesothelioma 01/2009 - 08/2008
2	Adenocarcinoma of Lung 04/2016 - 06/2015
1	Circulating Neoplastic Cells 12/2016
1	Carcinoma (Carcinomatosis) 08/2012
1	Genetic Translocation (Chromosomal Translocation) 08/2012
1	Squamous Cell Carcinoma of Head and Neck 11/2008
1	Malignant Mesothelioma 08/2008
1	Prostatic Neoplasms (Prostate Cancer) 09/2006

19	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2016 - 07/2006
14	ErbB Receptors (EGF Receptor)IBA 04/2016 - 07/2006
11	Gefitinib (Iressa)FDA Link 04/2016 - 07/2006
10	Tyrosine Kinase InhibitorsIBA 04/2016 - 11/2008
2	Cell-Free Nucleic AcidsIBA 12/2016 - 03/2014
2	LigandsIBA 12/2015 - 11/2008
2	Immune Checkpoint InhibitorsIBA 12/2015 - 06/2015
2	Monoclonal AntibodiesIBA 12/2015 - 08/2012
2	Bevacizumab (Avastin)FDA Link 06/2012 - 08/2008
1	CrizotinibIBA 03/2016
1	Phosphotransferases (Kinase)IBA 08/2015
1	Immunoglobulins (Immunoglobulin)IBA 06/2015
1	NivolumabIBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	ParaffinIBA 12/2012
1	Formaldehyde (Formol)FDA Link 12/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2012
1	8-dehydroxythienamycin (NS 5)IBA 06/2010
1	AsbestosIBA 01/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	AmphiregulinIBA 11/2008
1	Cetuximab (Erbitux)FDA Link 11/2008
1	AntibodiesIBA 11/2008
1	Epidermal Growth Factor (EGF)IBA 11/2008
1	Transforming Growth Factor alpha (TGF-alpha)IBA 11/2008
1	SteroidsIBA 09/2006
1	AndrogensIBA 09/2006
1	Ketoconazole (Nizoral)FDA LinkGeneric 09/2006
1	VA 061 (VA061)IBA 09/2006